10.2.2 Skeletal muscle relaxants

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

45 library items in 10.2.2 Skeletal muscle relaxants

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

10: Musculoskeletal and joint diseases (remove) , 10.2 Drugs used in neuromuscular disorders (remove) , 10.2.2 Skeletal muscle relaxants (remove)

Sort by: Display summary:

Results 1 - 10 of 45

Result page:
Previous
|
1
2
3
4
5
|
Next

1.

Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential

Source: Clinical Pharmacology and Therapeutics,
Date published: 01/03/2012

Category:

10.2.2 Skeletal muscle relaxants

NeLM Area:

Evidence > Medicines Management > References

Abstract link
2.

Study looks at associations between medication use and nocturnal leg cramps

Source: Arch Internal Med,
Date published: 13/12/2011

Category:

2.2 Diuretics | 3.1.1 Adrenoceptor agonists | 10.2.2 Skeletal muscle relaxants | Adverse Drug Reactions | Rheumatology

NeLM Area:

News

Link (abstract)
3.

NICE clinical guideline consultation: Spasticity in children and young people

Source: NICE,
Date published: 19/10/2011

Category:

10.2.2 Skeletal muscle relaxants | Clinical guidelines | National Institute of Clinical Excellence (NICE) | Neuromuscular disease

NeLM Area:

News

Link
4.

Tweets posted by Bayer Healthcare found to breach UK pharmaceutical industry Code of Conduct

Source: PharmaTimes,
Date published: 08/07/2011

Category:

7.4.5 Drugs for erectile dysfunction | 10.2.2 Skeletal muscle relaxants | Erectile dysfunction | IT | Law/ medical ethics/ litigation | Multiple sclerosis | Patient | Pharmaceutical Industry

NeLM Area:

News

PharmaTimes story (registration required)

Code of Conduct 2011
5.

Sativex®▼ for treatment of spasticity in multiple sclerosis

Source: Peninsula Health Technology Commissioning Group,
Date published: 06/07/2011

Category:

10.2.2 Skeletal muscle relaxants | Drug reviews | Multiple sclerosis

NeLM Area:

Evidence > Drug Specific Reviews

Sativex_for treatment_of_spasticity_MS
6.

NICE consults on whether to review its clinical guideline on multiple sclerosis

Source: NICE,
Date published: 03/05/2011

Category:

4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder | 4.11 Drugs for dementia | 10.2.2 Skeletal muscle relaxants | Clinical guidelines | Multiple sclerosis | National Institute of Clinical Excellence (NICE)

NeLM Area:

News

Link
7.

SMC unable to recommend cannabinoid (Sativex®) for spasticity in multiple sclerosis due to non-submission

Source: Scottish Medicines Consortium (SMC),
Date published: 12/04/2011

Category:

10.2.2 Skeletal muscle relaxants | Drug reviews | Multiple sclerosis | Scottish Medicines Consortium

NeLM Area:

Evidence > Drug Specific Reviews

Link
8.

Baclofen for alcohol withdrawal

Source: Cochrane Database of Systematic Reviews,
Date published: 30/03/2011

Category:

10.2.2 Skeletal muscle relaxants | Drug reviews | Drugs misuse

NeLM Area:

Evidence > Drug Specific Reviews

Link to Abstract
9.

Baclofen for alcohol withdrawal

Source: Cochrane Database of Systematic Reviews,
Date published: 30/03/2011

Category:

10.2.2 Skeletal muscle relaxants | Drugs misuse

NeLM Area:

Evidence > Drug Specific Reviews

Link to Abstract
10.

Annual Evidence Update on Multiple Sclerosis: 28 March - 1 April 2011

Source: NHS Evidence,
Date published: 28/03/2011

Category:

8.2.4 Other immunomodulating drugs | 10.2.2 Skeletal muscle relaxants | Information provision | Multiple sclerosis

NeLM Area:

News

Link

Results 1 - 10 of 45

Result page:
Previous
|
1
2
3
4
5
|
Next